other
UK medical products regulator running the AI Airlock pilot since April 2024 and expected to publish a new AI-in-medical-devices framework during 2026.
No evidence-backed relationships are recorded.
The $100m Series C doubles Heidi's valuation to $900m. The larger $240m tranche comes from a General Catalyst fund that can only pay for sales and marketing, and that holds no stock and no warrants in the company.
Reality
Years of cancer trials that boosted antioxidants failed, so a University of Vermont team tried stripping mesothelioma cells of one antioxidant enzyme instead, and an early-phase trial reports disease control in two-thirds of patients.
Reality
Healthwatch England says the 27 AI scribes now writing notes across the NHS in England are muddling drug names and diagnoses, and with no device classification from the MHRA, the last check is the patient.
Reality
The scribe errors Healthwatch documented reached patients' records before anyone queried them. In two of the cases, it was the patient who did the querying. England has 27 products in use and no device classification.
Reality
Removal notices dated 24 June 2026 gave ENDS merchants about two weeks, applied globally, and ignored both FDA authorisation and local law.
Reality
ECRI put AI in clinical diagnosis at number one on 9 March 2026. The absence of hearings, moratoria, or named vendors tells you what shape the constraint will actually take.
Reality